Dr. Krishna Ella, Co-founder and Executive Chairman of Bharat Biotech, received the Dean’s medal from the Johns Hopkins Bloomberg School of Public Health for his leadership and contribution to public health. The award was presented during a ceremony on May 22nd, 2024 in Baltimore, Maryland.
The Johns Hopkins Bloomberg School of Public Health recognized Dr. Ella’s work in developing safe vaccines for global public health. Dr. Ella expressed his gratitude for the award and dedicated it to Bharat Biotech and its team of scientists.
Bharat Biotech, under Dr. Ella’s guidance, has become a leader in biotechnology and vaccine innovation. They have developed over 19 vaccines, including the world’s first typhoid conjugate vaccine and a COVID-19 vaccine called COVAXIN®. The company has saved millions of lives globally with their vaccines.
Dr. Ella is also working on developing vaccines for diseases like Cholera, Malaria, Tuberculosis, and Zika. He has established world-class enterprises focused on human health and animal health.
Bharat Biotech has emerged as a global leader in vaccine development, with patents and vaccines distributed in 125 countries. Dr. Ella’s commitment to finding affordable vaccines for neglected diseases has made significant contributions to global health security.
Dr. Krishna Ella is known as the father of Genome Valley in Hyderabad for his contributions to vaccine research. He continues to inspire innovation and collaboration in the scientific community.
